First Capital Advisors Group LLC. reduced its position in SPDR S&P Biotech (NYSEARCA:XBI) by 13.0% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,298 shares of the exchange traded fund’s stock after selling 1,390 shares during the period. First Capital Advisors Group LLC.’s holdings in SPDR S&P Biotech were worth $718,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. National Planning Corp bought a new stake in shares of SPDR S&P Biotech during the second quarter worth $211,000. Boston Advisors LLC bought a new stake in shares of SPDR S&P Biotech during the second quarter worth $213,000. Telemus Capital LLC bought a new stake in shares of SPDR S&P Biotech during the second quarter worth $232,000. FineMark National Bank & Trust boosted its stake in shares of SPDR S&P Biotech by 7.4% in the second quarter. FineMark National Bank & Trust now owns 5,210 shares of the exchange traded fund’s stock worth $402,000 after buying an additional 360 shares in the last quarter. Finally, Meridian Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech during the second quarter worth $432,000.

Shares of SPDR S&P Biotech (NYSEARCA XBI) opened at 74.47 on Friday. SPDR S&P Biotech has a 12 month low of $53.15 and a 12 month high of $82.38. The firm has a 50 day moving average price of $78.58 and a 200-day moving average price of $71.46.

TRADEMARK VIOLATION WARNING: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2017/08/11/first-capital-advisors-group-llc-has-718000-stake-in-spdr-sp-biotech-nysearcaxbi.html.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.